| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 3 271-279, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
AF Quincoces and J Leon
Departamento de Biologia Molecular, Facultad de Medicina, Universidad de Cantabria, Santander, Spain.
We have analyzed the expression of the ras gene family during the transit through quiescence-proliferation. H-, K- and N-ras steady-state mRNA levels and total Ras protein levels did not change significantly when NIH3T3 cells were made quiescent by density arrest in the presence of 10% calf serum. By contrast, levels of ras mRNAs in cells that had been made quiescent by serum deprivation were lower than those in growing cells. An induction of H-, K- and N-ras mRNA levels (3- to 5-fold) was detected in these cells after serum addition. This induction was maximal around 8 h after serum addition for the three ras genes. Like the early-response genes, ras induction was not dependent on protein synthesis; but in contrast to these genes, ras mRNAs showed long half-lives (5-7 h) in NIH3T3 cells. Up-regulation of ras genes by serum was also observed in human primary fibroblasts, indicating that this may be a general effect in mammal cells. We obtained stable transfectants in NIH3T3 cells with the oncogenic N-ras. In these cells, expression of the transforming gene is also induced by serum, and the expression of the transfected N-ras gene did not modify the response to serum of endogenous H-, K-, and N-ras genes. The regions of murine N-ras gene responsible for serum inducibility seem to be intragenic because N-ras up-regulation occurred in cells transfected with a gene construct lacking the sequences upstream from the first exon.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
J. P. Vaque, B. Fernandez-Garcia, P. Garcia-Sanz, N. Ferrandiz, G. Bretones, F. Calvo, P. Crespo, M. C. Marin, and J. Leon c-Myc Inhibits Ras-Mediated Differentiation of Pheochromocytoma Cells by Blocking c-Jun Up-Regulation Mol. Cancer Res., February 1, 2008; 6(2): 325 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Psahoulia, S. Moumtzi, M. L. Roberts, T. Sasazuki, S. Shirasawa, and A. Pintzas Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells Carcinogenesis, May 1, 2007; 28(5): 1021 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Santangelo, B. Nix, A. Tsourkas, and G. Bao Dual FRET molecular beacons for mRNA detection in living cells Nucleic Acids Res., April 14, 2004; 32(6): e57 - e57. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Taylor and C. A. McNamara Regulation of Vascular Smooth Muscle Cell Growth: Targeting the Final Common Pathway Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1717 - 1720. [Full Text] [PDF] |
||||
![]() |
T. Bakheet, M. Frevel, B. R. G. Williams, W. Greer, and K. S. A. Khabar ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins Nucleic Acids Res., January 1, 2001; 29(1): 246 - 254. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |